NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,058,543 | -24.1% | 55,076 | +0.4% | 0.00% | -50.0% |
| Q2 2023 | $1,394,007 | +81804.1% | 54,839 | +16.5% | 0.00% | 0.0% |
| Q1 2023 | $1,702 | -7.2% | 47,080 | +1.6% | 0.00% | 0.0% |
| Q4 2022 | $1,835 | -99.9% | 46,336 | +3.5% | 0.00% | -33.3% |
| Q3 2022 | $2,087,000 | +14.9% | 44,778 | +8.0% | 0.00% | 0.0% |
| Q2 2022 | $1,816,000 | -30.5% | 41,443 | +14.7% | 0.00% | 0.0% |
| Q1 2022 | $2,614,000 | -10.3% | 36,136 | +0.6% | 0.00% | -25.0% |
| Q4 2021 | $2,913,000 | -31.6% | 35,926 | -1.8% | 0.00% | -33.3% |
| Q3 2021 | $4,260,000 | -28.6% | 36,602 | +1.7% | 0.01% | -25.0% |
| Q2 2021 | $5,966,000 | +13.9% | 35,986 | -4.2% | 0.01% | +14.3% |
| Q1 2021 | $5,239,000 | -28.7% | 37,553 | -11.5% | 0.01% | -30.0% |
| Q4 2020 | $7,347,000 | +28.5% | 42,444 | +3.4% | 0.01% | +11.1% |
| Q3 2020 | $5,716,000 | -8.5% | 41,034 | -21.5% | 0.01% | -10.0% |
| Q2 2020 | $6,245,000 | +43.7% | 52,276 | +20.3% | 0.01% | +11.1% |
| Q1 2020 | $4,345,000 | -13.8% | 43,457 | +1.3% | 0.01% | +12.5% |
| Q4 2019 | $5,041,000 | +44.2% | 42,887 | +5.4% | 0.01% | +33.3% |
| Q3 2019 | $3,497,000 | +31.5% | 40,672 | -0.8% | 0.01% | +20.0% |
| Q2 2019 | $2,659,000 | +11.6% | 41,018 | +7.6% | 0.01% | 0.0% |
| Q1 2019 | $2,383,000 | +56.9% | 38,124 | -2.4% | 0.01% | +66.7% |
| Q4 2018 | $1,519,000 | -0.4% | 39,058 | +46.0% | 0.00% | 0.0% |
| Q3 2018 | $1,525,000 | -33.1% | 26,757 | -6.2% | 0.00% | -40.0% |
| Q2 2018 | $2,278,000 | -5.0% | 28,525 | +3.1% | 0.01% | 0.0% |
| Q1 2018 | $2,398,000 | +23.7% | 27,669 | -1.5% | 0.01% | +25.0% |
| Q4 2017 | $1,939,000 | -35.8% | 28,084 | -15.5% | 0.00% | -42.9% |
| Q3 2017 | $3,020,000 | +28.8% | 33,235 | +5.5% | 0.01% | +40.0% |
| Q2 2017 | $2,344,000 | -11.7% | 31,491 | +11.1% | 0.01% | -16.7% |
| Q1 2017 | $2,655,000 | +34.2% | 28,339 | +4.0% | 0.01% | +20.0% |
| Q4 2016 | $1,979,000 | -26.2% | 27,239 | +6.1% | 0.01% | -28.6% |
| Q3 2016 | $2,681,000 | +57.1% | 25,679 | +10.9% | 0.01% | +40.0% |
| Q2 2016 | $1,707,000 | +79.5% | 23,149 | +36.9% | 0.01% | +66.7% |
| Q1 2016 | $951,000 | -13.2% | 16,905 | +4.3% | 0.00% | -25.0% |
| Q4 2015 | $1,095,000 | +66.2% | 16,215 | +14.2% | 0.00% | +100.0% |
| Q3 2015 | $659,000 | -4.1% | 14,195 | +11.1% | 0.00% | 0.0% |
| Q2 2015 | $687,000 | +150.7% | 12,775 | +123.3% | 0.00% | +100.0% |
| Q1 2015 | $274,000 | – | 5,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |